Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer.


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
15 02 2022
Historique:
received: 22 10 2020
revised: 16 09 2021
accepted: 11 11 2021
pubmed: 19 11 2021
medline: 8 4 2022
entrez: 18 11 2021
Statut: ppublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC) remains a significant health issue. For most patients, there are no options for targeted therapy, and existing treatments are limited by toxicity. The HOPE trial (Harnessing Organoids for PErsonalized Therapy) was a pilot feasibility trial aiming to prospectively generate patient-derived organoids (PDO) from patients with PDAC and test their drug sensitivity and correlation with clinical outcomes. PDOs were established from a heterogeneous population of patients with PDAC including both basal and classical PDAC subtypes. A method for classifying PDOs as sensitive or resistant to chemotherapy regimens was developed to predict the clinical outcome of patients. Drug sensitivity testing on PDOs correlated with clinical responses to treatment in individual patients. These data support the investigation of PDOs to guide treatment in prospective interventional trials in PDAC.

Identifiants

pubmed: 34789479
pii: 1078-0432.CCR-20-4116
doi: 10.1158/1078-0432.CCR-20-4116
pmc: PMC8866201
mid: NIHMS1771723
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

708-718

Subventions

Organisme : NCI NIH HHS
ID : K08 CA248473
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002541
Pays : United States
Organisme : Judy and Kim Davis.
ID : ERC-2014-ADG-670582

Informations de copyright

©2021 American Association for Cancer Research.

Références

Nat Commun. 2019 Oct 18;10(1):4729
pubmed: 31628300
Sci Rep. 2019 Aug 2;9(1):11239
pubmed: 31375762
Cell Stem Cell. 2020 Jan 2;26(1):17-26.e6
pubmed: 31761724
Cancer Discov. 2018 Sep;8(9):1096-1111
pubmed: 29903880
Nat Genet. 2015 Oct;47(10):1168-78
pubmed: 26343385
Cancer Cell. 2015 Oct 12;28(4):411-413
pubmed: 26461089
J Clin Oncol. 2012 Feb 1;30(4):e45-8
pubmed: 22184402
Cancer Discov. 2018 Sep;8(9):1112-1129
pubmed: 29853643
JCI Insight. 2020 Nov 5;5(21):
pubmed: 32990680
Cancer Discov. 2017 May;7(5):462-477
pubmed: 28331002
Science. 2019 Jun 07;364(6444):952-955
pubmed: 31171691
Science. 2008 Sep 26;321(5897):1801-6
pubmed: 18772397
Lancet Oncol. 2020 Apr;21(4):508-518
pubmed: 32135080
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):207-220
pubmed: 30718832
Cell. 2017 Dec 14;171(7):1678-1691.e13
pubmed: 29245013
PLoS Comput Biol. 2019 Jan 10;15(1):e1006596
pubmed: 30629588
Clin Cancer Res. 2017 Oct 15;23(20):6094-6100
pubmed: 28754816
Bioinformatics. 2010 Jun 15;26(12):1572-3
pubmed: 20427518
J Natl Compr Canc Netw. 2018 Jul;16(7):807-821
pubmed: 30006423
Clin Cancer Res. 2018 Oct 15;24(20):5018-5027
pubmed: 29954777
Cancer Discov. 2014 Sep;4(9):998-1013
pubmed: 25185190
Gastrointest Endosc. 2018 Jun;87(6):1474-1480
pubmed: 29325707
Clin Cancer Res. 2020 Sep 15;26(18):4901-4910
pubmed: 32156747
Nature. 2016 Mar 3;531(7592):47-52
pubmed: 26909576
Proc Natl Acad Sci U S A. 2019 Dec 9;:
pubmed: 31818951
Cell. 2015 Jan 15;160(1-2):324-38
pubmed: 25557080
Sci Rep. 2018 Mar 28;8(1):5319
pubmed: 29593296
N Engl J Med. 2019 Jul 25;381(4):317-327
pubmed: 31157963
Nat Cancer. 2020 Jan;1(1):59-74
pubmed: 35118421
Mol Cancer Ther. 2011 Jan;10(1):3-8
pubmed: 21135251
Clin Cancer Res. 2014 May 1;20(9):2476-84
pubmed: 24634382
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
J Natl Compr Canc Netw. 2019 May 1;17(5.5):603-605
pubmed: 31117041
Mol Cancer Ther. 2011 Aug;10(8):1311-6
pubmed: 21673092
Nat Med. 2015 Nov;21(11):1364-71
pubmed: 26501191
Science. 2018 Feb 23;359(6378):920-926
pubmed: 29472484

Auteurs

Joseph E Grossman (JE)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Lakshmi Muthuswamy (L)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Ling Huang (L)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Dipikaa Akshinthala (D)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Sofia Perea (S)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Raul S Gonzalez (RS)

Harvard Medical School, Boston, Massachusetts.
BIDMC Department of Pathology, Harvard Medical School, Boston, Massachusetts.

Leo L Tsai (LL)

Harvard Medical School, Boston, Massachusetts.
BIDMC Department of Radiology, Harvard Medical School, Boston, Massachusetts.

Jonah Cohen (J)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Bruno Bockorny (B)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Andrea J Bullock (AJ)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Benjamin Schlechter (B)

Harvard Medical School, Boston, Massachusetts.
Dana-Farber Cancer Institute, Boston, Massachusetts.

Mary Linton B Peters (MLB)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Catherine Conahan (C)

Boston College, Connell School of Nursing, Newton, Massachusetts.

Supraja Narasimhan (S)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Christine Lim (C)

Nanyang Technological University, Singapore, Singapore.

Roger B Davis (RB)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Robert Besaw (R)

BIDMC Cancer Clinical Trials Office, Harvard Medical School, Boston, Massachusetts.

Mandeep S Sawhney (MS)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Douglas Pleskow (D)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Tyler M Berzin (TM)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Martin Smith (M)

Harvard Medical School, Boston, Massachusetts.
BIDMC Department of Radiology, Harvard Medical School, Boston, Massachusetts.

Tara S Kent (TS)

Harvard Medical School, Boston, Massachusetts.
BIDMC Department of Surgery, Harvard Medical School, Boston, Massachusetts.

Mark Callery (M)

Harvard Medical School, Boston, Massachusetts.
BIDMC Department of Surgery, Harvard Medical School, Boston, Massachusetts.

Senthil K Muthuswamy (SK)

BIDMC Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Manuel Hidalgo (M)

Weill Cornell Medicine/New York-Presbyterian Hospital, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH